Israel state records י"ג בשבט התשס"ח January 20, 2008

מערכת ללכידה והקלטה דיגיטלית של תמונות פנורמיות	SYSTEM FOR DIGITALLY CAPTURING AND RECORDING PANORAMIC IMAGES
[54]
	15.07.1999					[22]
	US	[33]	12.05.1999	[32]	310715	[31]
	US		23.06.1999		338790
Int. Cl.8 H04N 005/232, 005/77, 007/18, 009/804, 009/806, 009/82						[51]
			IMOVE, INC., U.S.A.			[71]
			SCOTT GILBERT, DAVID KAIMAN, MICHAEL C. PARK, DAVID C. RIPLEY			[72]
	WO/2000/070486					[87]
ירמיהו מ. בן-דוד ושות' בע"מ, רחוב המרפא, הר חוצבים , ת.ד. 45087, ירושלים			JEREMY M. BEN-DAVID & CO. LTD., HAR HOTZVIM HI-TECH PARK, P.O.B. 45087, JERUSALEM 91450			[74]

[57] A digital image capture system which includes, a digital image capture unit which simultaneously captures a plurality of overlapping digital images utilizing a non-interleaved progressive scan, a control computer, a control link and a data capture link between said control computer and said image capture unit whereby a digital image from said image capture unit can be transferred to said control computer and said control computer can send control signals to said digital image capture unit.

__________

146435			[21][11]
תכשירי רוקחות המכילים נוגדנים המתקשרים לפפטיד–בטא עמילויד			PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBODIES THAT BIND TO BETA-AMYLOID PEPTIDE			[54]
	26.05.2000					[22]
	US	[33]	28.05.1999	[32]	09/322289	[31]
Int. Cl.8 A61K 038/06, 038/08, 038/10, 039/395, A61P 025/28, 037/04, C07K 005/08, 005/10, 007/06, 007/08, 019/00						[51]
			NEURALAB LIMITED, BERMUDA			[71]
	WO/2000/072880					[87]
וולף, ברגמן וגולר, רחוב קרן היסוד 19ב' , ת.ד. 1352, ירושלים			WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST., P.O.B. 1352, JERUSALEM 91013			[74]

[57] A pharmaceutical composition comprising a chimeric or humanized antibody that specifically binds to an epitope within residues 1-10 of Aβ, and a pharmaceutically acceptable carrier.

בקשות חלוקה מבקשה זו שטרם פורסמו.		187526,		The applications for division from this application have not yet been published

__________

146450			[21][11]
אינטראקציות של חלבון עם חלבון ושיטה לזיהוי חלבונים המשתתפים באינטראקציות ורצף חומצות–האמין באתר האינטראקציה			PROTEIN-PROTEIN INTERACTIONS AND METHODS FOR IDENTIFYING INTERACTING PROTEINS AND THE AMINO ACID SEQUENCE AT THE SITE OF INTERACTION			[54]
	12.05.2000					[22]
	US	[33]	14.05.1999	[32]	60/134259	[31]
Int. Cl.8 G01N 033/68						[51]
			ELIAS GEORGES, CANADA			[71]
	WO/2000/070351					[87]
זליגסון גבריאלי ושות', רח' יבנה 31 , ת.ד. 1426, תל אביב			SELIGSOHN GABRIELI & CO., 31 YAVNE ST., P.O.B. 1426, TEL AVIV 61013			[74]

[57] A method for identifying a polypeptide that binds to a peptide in a chosen protein wherein said polypeptide is not an antibody, comprising:

(a) providing a set of overlapping peptides spanning a complete sequence of at least a domain of the chosen protein, the set of overlapping peptides being covalently attached to a support;

(b) contacting the support to which the overlapping peptides are covalently attached with a mixture of polypeptides under conditions enabling binding between the peptides on the support and a polypeptide of the mixture;

(c) washing the support to remove unbound polypeptides of the mixture; and

(d) identifying a polypeptide that is retained on the support,

wherein the polypeptide that is retained on the support is the polypeptide that binds to the peptide in the chosen protein.

__________

146545			[21][11]
נגזרות בנזין, שיטת הכנתן והרכבים רקחיים המכילים אותן			BENZENE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME			[54]
	08.06.2000					[22]
	FR	[33]	11.06.1999	[32]	99/07396	[31]
Int. Cl.8 C07C 211/00						[51]
			SANOFI AVENTIS, FRANCE			[71]
	WO/2000/076953					[87]
סנפורד ט. קולב ושות', שער הגיא 4, מרמורק , ת.ד. 2273, רחובות			SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122			[74]

[57] Compounds of the formula:

in which:

A represents a group chosen from the following:

-C≡C-, -CH=CH-; -CH₂-CH₂-;

n is equal to 1 to 2;

X represents a hydrogen, chlorine of fluorine atom or a methyl or methoxy group;

Y represents a hydrogen atom or a chlorine or fluorine atom;

R₁ represents a cyclohexyl group monosubstituted, disubstituted, trisubstituted or tetrasubstituted with a methyl group; a phenyl group monosubstituted or disubstituted with a fluorine or chlorine atom or with a methoxy group; a cyclohepthyl, tert-butyl, dicyclopropylmethyl, bicyclo[3.2.1]octanyl, 4-tetrahydropyranyl, 4-tetrahydro-thiopyranyl or 1-or 2-adamantyl or adamantan-2-ol group; or R₁ represents a phenyl group, it being understood that, in this case, X and Y are other than hydrogen;

R₂ represents a hydrogen atom or a (C₁-C₄) alkyl group optionally substituted with a trifluoromethyl group; R₃ represents a (C₅-C₇) cycloalkyl; and the addition salts of these compounds with pharmaceutically acceptable acids, as well as the solvates and hydrates thereof.

__________

146861		[21][11]
שיטה לטיפול קריאוגני ומערכת ליישום השיטה		METHOD AND SYSTEM FOR CRYOGENIC TREATMENT	[54]
	02.12.2001		[22]
Int. Cl.8 F25D 003/11			[51]
קראיובאר בע"מ, קרית גת		CRYOBEAR LTD.	[71]
יולי ברדיצ'בסקי, הלנה ז'מוד, יצחק לדיז'נסקי		YULI BERDICHEVSKY, HELEN ZHMUD, IZHAK LADIZHENSKY	[72]
ד"ר דוד אגרנוב, , ת.ד. 15, אלוני-אבא		DR. DAVID AGRANOV, P.O.B. 15, ALONEY-ABA 36005	[74]

[57] A method for cryogenic treatment comprising bringing of at least one article of manufacture in contact with a cryogenic medium, said method comprising

(a) providing a covering around the article before bringing thereof in contact with the cryogenic medium, wherein said covering is provided with openings which expose to the cryogenic medium discrete locations on the surfaces of the article, and

(b) removing said covering from the article after the cryogenic treatment is completed.

__________

146944			[21][11]
תכשירי רוקחות המכילים קלטורים של ברזל לטיפול במחלות עצבים וקלטורים של ברזל חדשים מסוימים			PHARMACEUTICAL COMPOSITIONS COMPRISING IRON CHELATORS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS AND SOME NOVEL IRON CHELATORS			[54]
	07.06.2000					[22]
	IL	[33]	07.06.1999	[32]	130324	[31]
Int. Cl.7 A61K 031/16, C07C 237/04						[51]
ידע חברה למחקר ופיתוח בע"מ, רחובות מוסד הטכניון למחקר ופיתוח בע"מ, חיפה			YEDA RESEARCH AND DEVELOPMENT CO. LTD. TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.			[71]
אברהם ורשבסקי, משה ב.ח. יודעים, דורית בן-שחר			ABRAHAM WARSHAWSKY, MOUSSA B.H. YOUDIM, DORIT BEN-SHACHAR			[72]
	WO/2000/074664					[87]
פאולינה בן-עמי , בן עמי ושות', ת.ד. 94, רחובות			PAULINA BEN-AMI, BEN-AMI & ASSOCIATES, P.O.B. 94, REHOVOT 76100			[74]

[57] Use of a compound of the formula

wherein

R¹ is H or hydrocarbyl; R² is a hydrophobic radical; R³ is a radical selected from 3-(C₂-C₆) acyl-4-hydroxyphenyl, 3-hydroxyimino (C₂-C₆) alkyl-4-hydroxyphenyl, or COOZ, wherein Z is H, (C₁-C₆) alkyl, aryl or ar (C₁-C₆) alkyl; and n is an integer from 1 to 20;

or (b) a compound of the formula

wherein

R⁴ is (C₁-C₆) acyl, nitro (C₁-C₆) alkyl, cyano (C₁-C₆) alkyl, (C₁-C₆) alkoxy (C₁-C₆) alkyl or-CH₂NR⁷R⁸, wherein R⁷ and R⁸, the same or different, is each H or (C₁-C₆) alkyl, or together with the N atom form a saturated or unsaturated 5-7 membered ring optionally containing a further heteroatom selected from N, O or S, the further N atom in such saturated 5-7 membered ring being optionally substituted by (C₁-C₆) alkyl, (C₁-C₆) acyl, hydroxy-(C₁-C₆) alkyl, (C₁-C₆) alkoxycarbonyl, and 8-hydroxyquinolin-5-yl-(C₁-C₆) alkyl, and either R⁵ is H and R⁶ is (C₂-C₆) acyl or hdyroxyimino (C₂-C₆) alkyl, or R⁵ and R⁶ together with the phenyl ring form a quinoline, a 1,2,3,4-tetrahydroquinoline or a perhydroquinoline ring, or pharmaceutically acceptable salts thereof, for the preparation of a pharmaceutical composition for prevention of lipid peroxidation in the brain of mammals and thus for treatment of neurodegenerative disorders.

__________

146945			[21][11]